These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 24456746)

  • 1. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
    Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
    Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
    Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
    Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice.
    Zhang CT; Lin JR; Wu F; Ghosh A; Tang SS; Hu M; Long Y; Sun HB; Hong H
    Neurotoxicology; 2016 Dec; 57():214-222. PubMed ID: 27702591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo.
    Tang SS; Hong H; Chen L; Mei ZL; Ji MJ; Xiang GQ; Li N; Ji H
    Neurobiol Aging; 2014 Mar; 35(3):590-9. PubMed ID: 24269024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chotosan improves Aβ1-42-induced cognitive impairment and neuroinflammatory and apoptotic responses through the inhibition of TLR-4/NF-κB signaling in mice.
    Chen L; Hu L; Zhao J; Hong H; Feng F; Qu W; Liu W
    J Ethnopharmacol; 2016 Sep; 191():398-407. PubMed ID: 26994819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with antiasthmatic drug ibudilast ameliorates Aβ 1-42-induced memory impairment and neurotoxicity in mice.
    Wang H; Mei Zl; Zhong KL; Hu M; Long Y; Miao MX; Li N; Yan TH; Hong H
    Pharmacol Biochem Behav; 2014 Sep; 124():373-9. PubMed ID: 25038445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice.
    Tang SS; Wang XY; Hong H; Long Y; Li YQ; Xiang GQ; Jiang LY; Zhang HT; Liu LP; Miao MX; Hu M; Zhang TT; Hu W; Ji H; Ye FY
    Neuropharmacology; 2013 Feb; 65():182-92. PubMed ID: 22982445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CysLT
    Ghosh A; Chen F; Wu F; Tang SS; Hu M; Long Y; Sun HB; Kong LY; Hong H
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Feb; 73():19-30. PubMed ID: 27720931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease.
    Sachdeva AK; Chopra K
    J Nutr Biochem; 2015 Jul; 26(7):736-44. PubMed ID: 25869595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in mice.
    An YQ; Zhang CT; Du Y; Zhang M; Tang SS; Hu M; Long Y; Sun HB; Hong H
    Metab Brain Dis; 2016 Jun; 31(3):663-71. PubMed ID: 26864581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of pranlukast on Aβ₁₋₄₂-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1.
    Tang SS; Ji MJ; Chen L; Hu M; Long Y; Li YQ; Miao MX; Li JC; Li N; Ji H; Chen XJ; Hong H
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):581-92. PubMed ID: 24229499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive effect of genetic knockdown and pharmacological blockade of CysLT
    Chen F; Ghosh A; Wu F; Tang S; Hu M; Sun H; Kong L; Hong H
    Brain Behav Immun; 2017 Feb; 60():255-269. PubMed ID: 27810377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of INT-777 against Aβ
    Wu X; Lv YG; Du YF; Chen F; Reed MN; Hu M; Suppiramaniam V; Tang SS; Hong H
    Brain Behav Immun; 2018 Oct; 73():533-545. PubMed ID: 29935310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats.
    Wang C; Yang XM; Zhuo YY; Zhou H; Lin HB; Cheng YF; Xu JP; Zhang HT
    Int J Neuropsychopharmacol; 2012 Jul; 15(6):749-66. PubMed ID: 21733236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthoceraside attenuates amyloid β peptide
    Qi Y; Ji XF; Chi TY; Liu P; Jin G; Xu Q; Jiao Q; Wang LH; Zou LB
    Eur J Pharmacol; 2018 Feb; 820():18-30. PubMed ID: 29229533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pratensein ameliorates β-amyloid-induced cognitive impairment in rats via reducing oxidative damage and restoring synapse and BDNF levels.
    Liang C; Tan S; Huang Q; Lin J; Lu Z; Lin X
    Neurosci Lett; 2015 Apr; 592():48-53. PubMed ID: 25748315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of mogrol against Aβ
    Chen G; Liu C; Meng G; Zhang C; Chen F; Tang S; Hong H; Zhang C
    J Pharm Pharmacol; 2019 May; 71(5):869-877. PubMed ID: 30585314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
    Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
    Oncol Rep; 2018 Aug; 40(2):902-908. PubMed ID: 29845257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.